Identification of biomarkers to improve diagnostic sensitivity of sporadic colorectal cancer in patients with low preoperative serum carcinoembryonic antigen by clinical proteomic analysis

Clinica Chimica Acta

Volumn 412, Issue 7-8, 2011, Pages 636-641

  Chen, William Tzu Liang ^a,b   Chang, Sheng Chi ^a   Ke, Tao Wei ^a   Chiang, Hua Che ^a   Tsai, Fuu Jen ^c   Lo, Wan Yu ^a,c  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Biomarker; Carcinoembryonic antigen; Colorectal cancer; Microdissection; Proteomics

Indexed keywords

ALPHA ENOLASE; CARCINOEMBRYONIC ANTIGEN; HEAT SHOCK PROTEIN 27; MACROPHAGE MIGRATION INHIBITION FACTOR;

ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE MARKER; FEASIBILITY STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; LASER PRESSURE CATAPULTING; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; PREDICTION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEOMICS; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS;

BLOTTING, WESTERN; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; PROTEOMICS; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 79551480602     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.12.024     Document Type: Article

References (34)

1. Lievre A., Laurent-Puig P. P Mol biology clinical cancer research example digestive cancers. Rev Épidémiol Santé Publique 2005, 53(3):267-282.
2. Dolderer J.H., Schuldes H., Bockhorn H. HERG1 gene expression as a specific tumor marker in colorectal tissues. Eur J Surg Oncol 2010, 36:72-77.
3. Duffy M.J., Van Dalen A., Haglund C., et al. Clinical utility of biochemical markers in colorectal cancer: European Group on tumour Markers (EGTM) guidelines. Eur J Cancer 2003, 39:718-737.
4. Xu X.L., Yu J., Zhang H.Y., et al. Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis. World J Gastroentero 2004, 10:3441-3454.
5. Ancona N., Maglietta R., Piepoli A., et al. On the statistical assessment of classifiers using DNA microarray data. BMC Bioinform 2006, 7:387-400.
6. Cheng Y., Zhang J., Li Y., et al. Proteome analysis of human gastric cardia adenocarcinoma by laser capture microdissection. BMC Cancer 2007, 7:191.
7. Bi X., Lin Q., Foo T.W., et al. Proteomic analysis of colorectal cancer reveals alterations in metabolic pathways mechanism of tumorigenesis. Mol Cell Proteomics 2006, 5:1119-1130.
8. Skandarajah A.R., Moritz R.L., Tjandra J.J., et al. Proteomic analysis of colorectal cancer: discovering novel biomarkers. Expert Rev Proteomics 2005, 2:681-692.
9. Xing X.M., Lai M.D., Gartner W., et al. Identification of differentially expressed proteins in colorectal cancer by proteomics: down-regulation of secretagogin. Proteomics 2006, 6:2916-2923.
10. Bazan V., La Rocca G., Corsale S., et al. Laser pressure catapulting (LPC): optimization LPC-system and genotyping of colorectal carcinomas. J Cell Physiol 2005, 202:503-509.
11. Niyaz Y., Stich M., Sägmüller B. Noncontact laser microdissection and pressure catapulting: sample preparation for genomic, transcriptomic, and proteomic analysis. Meth Mol Med 2005, 114:1-24.
12. Lo W.Y., Lai C.C., Hua C.H., et al. S100A8 is identified as a biomarker of HPV18-infected oral squamous cell carcinomas by suppression subtraction hybridization, clinical proteomics analysis, and immunohistochemistry staining. J Proteome Res 2007, 6:2143-2151.
13. Van't Veer L.J., Dai H.Y., van de Vijver M.J., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415:530-536.
14. Chuthapisith S., Layfield R., Kerr I.D., et al. Principles of proteomics and its applications in cancer. Surgeon 2007, 5:14-22.
15. Keohavong P., Gao W.M., Zheng K.C., et al. Detection of K-ras and p53 mutations in sputum samples of lung cancer patients using laser capture microdissection microscope and mutation analysis. Anal Biochem 2004, 324:92-99.
16. Hunt J.L., Swalsky P., Sasatomi E., et al. A microdissection and molecular genotyping assay to confirm the identity of tissue floaters in paraffin-embedded tissue blocks. Arch Pathol Lab Med 2003, 127:213-217.
17. Lawrie L.C., Curran S., McLeod H.L., et al. Application of laser capture microdissection and proteomics in colon cancer. Mol Pathol 2001, 54:253-258.
18. Dundas S.R., Lawrie L.C., Rooney P.H., et al. Mortalin is over-expressed by colorectal adenocarcinomas and correlates with poor survival. J Pathol 2005, 205:74-81.
19. Alfonso P., Nunez A., Madoz-Gurpide J., et al. Proteomic expression analysis of colorectal cancer by two-dimensional differential gel electrophoresis. Proteomics 2005, 5:2602-2611.
20. Friedman D.B., Hill S., Keller J.W., et al. Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry. Proteomics 2004, 4:793-811.
21. Zhang D.H., Tai L.K., Teh M., et al. Comparative proteomics of colorectal cancer: abnormal expression of proteins within the tumor nest and implication of HnRNP A1 as an oncoprotein in tumorigenesis. J Cancer Mol 2006, 2:17-24.
22. So A., Hadaschik B., Sowery R., et al. The role of stress proteins in prostate cancer. Curr Genomics 2007, 8:252-261.
23. Conroy S.E., Sasieni P.D., Amin V., et al. Antibodies to heat-shock protein 27 are associated with improved survival in patients with breast cancer. Br J Cancer 1998, 77:1875-1879.
24. Arts H.J., Hollema H., Lemstra W., et al. Heat-shock-protein-27 (hsp27) expression in ovarian carcinoma: relation in response to chemotherapy and prognosis. Int J Cancer 1999, 84:234-238.
25. Kapranos N., Kominea A., Konstantinopoulos P.A., et al. Expression of the 27-kDa heat shock protein (HSP27) in gastric carcinomas and adjacent normal, metaplastic, and dys-plastic gastric mucosa, and its prognostic significance. J Cancer Res Clin Oncol 2002, 128:426-432.
26. Lo W.Y., Tsai M.H., Tsai Y., et al. Identification of over-expressed proteins in oral squamous cell carcinoma (OSCC) patients by clinical proteomic analysis. Clin Chim Acta 2007, 376:101-107.
27. Kanemoto K., Satoh H., Ishikawa H., et al. Neurone-specific enolase and liver metastasis in small cell lung cancer. Clin Oncol 2006, 18:505.
28. Afjehi-Sadat L., Gruber-Olipitz M., Felizardo M., et al. Expression of proteasomal proteins in ten different tumor cell lines. Amino Acids 2004, 27:129-140.
29. Mosca M., Chimenti D., Pratesi F., et al. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus. J Rheumatol 2006, 33:695-697.
30. Altenberg B., Greulich K.O. Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics 2004, 84:1014-1020.
31. Reuning U., Magdolen V., Wilhelm O., et al. Multifunctional potential of the plasminogen activation system in tumor invasion and metastasis (review). Int J Oncol 1998, 13:893-906.
32. Mitchell R.A. Mechanisms and effectors of MIF-dependent promotion of tumourigenesis. Cell Signal 2004, 16:13-19.
33. Wilson J.M., Coletta P.L., Cuthbert R.J., et al. Macrophage migration inhibitory factor promotes intestinal tumorigenesis. Gastroenterology 2005, 129:1485-1503.
34. Lee H., Rhee H., Kang H.J. Macrophage migration inhibitory factor may be used as an early diagnostic marker in colorectal carcinomas. Am J Clin Pathol 2008, 129:772-779.